Literature DB >> 6779933

Management of hepatic encephalopathy.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6779933      PMCID: PMC1503997     

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  7 in total

1.  Treatment and prevention of acute hepatic encephalopathy by intravenous levodopa.

Authors:  O Abramsky; Z Goldschmidt
Journal:  Surgery       Date:  1974-02       Impact factor: 3.982

2.  Levodopa in hepatic coma.

Authors:  J D Parkes; P Sharpstone; R Williams
Journal:  Lancet       Date:  1970-12-26       Impact factor: 79.321

3.  L-dopa in hepatic coma.

Authors:  J E Fischer; F J Funovics; H A Falcao; R I Wesdorp
Journal:  Ann Surg       Date:  1976-04       Impact factor: 12.969

4.  Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial.

Authors:  M Uribe; A Farca; M A Márquez; G Garcĭa-Ramos; L Guevara
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

5.  Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy.

Authors:  M Y Morgan; A W Jakobovits; I M James; S Sherlock
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

6.  Treatment of chronic hepatic encephalopathy with levodopa.

Authors:  M Lunzer; I M James; J Weinman; S Sherlock
Journal:  Gut       Date:  1974-07       Impact factor: 23.059

7.  Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.

Authors:  H Michel; M Solere; P Granier; G Cauvet; J P Bali; F Pons; H Bellet-Hermann
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.